Hormonal breast cancer agents: implications for the primary care provider.
作者： Debra E. Lyon , Gayle Roux , Sandra Voll
DOI: 10.1111/J.1745-7599.2006.00168.X
关键词:
摘要: Purpose: Over 2 million breast cancer survivors are in the United States, making women with largest group of survivors. The purpose this article is to review current knowledge regarding survivorship issues early-stage, estrogen receptor–positive cancer, focusing on advances hormonal therapies for reducing risk recurrence. Data sources: Published research studies, clinical treatment guidelines, and ongoing trials. Conclusions: Innovations antiestrogenic modulator an important aspect care after primary treatment. Primary providers may play role monitoring potential complications treatment. Implications practice: This reviews state science agents With high incidence prevalence need be aware short- long-term health risks benefits
sci-hub.se 参考文章(33)
D Lawrence Wickerham, Bernard Fisher, Norman Wolmark, John Bryant, Joseph Costantino, Leslie Bernstein, Carolyn D Runowicz, None, Association of tamoxifen and uterine sarcoma. Journal of Clinical Oncology. ,vol. 20, pp. 2758- 2760 ,(2002) , 10.1200/JCO.2002.20.11.2758
Wendy Demark-Wahnefried, Bercedis L. Peterson, Eric P. Winer, Lawrence Marks, Noreen Aziz, P. Kelly Marcom, Kimberly Blackwell, Barbara K. Rimer, Changes in Weight, Body Composition, and Factors Influencing Energy Balance Among Premenopausal Breast Cancer Patients Receiving Adjuvant Chemotherapy Journal of Clinical Oncology. ,vol. 19, pp. 2381- 2389 ,(2001) , 10.1200/JCO.2001.19.9.2381
Clodia Osipo, Hong Liu, Kathleen Meeke, V. Craig Jordan, The consequences of exhaustive antiestrogen therapy in breast cancer: estrogen-induced tumor cell death. Experimental Biology and Medicine. ,vol. 229, pp. 722- 731 ,(2004) , 10.1177/153537020422900804
F P Li, E L Stovall, Long-term survivors of cancer. Cancer Epidemiology, Biomarkers & Prevention. ,vol. 7, pp. 269- 270 ,(1998)
B Fisher, A Brown, E Mamounas, S Wieand, A Robidoux, R G Margolese, A B Cruz, E R Fisher, D L Wickerham, N Wolmark, A DeCillis, J L Hoehn, A W Lees, N V Dimitrov, Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. Journal of Clinical Oncology. ,vol. 15, pp. 2483- 2493 ,(1997) , 10.1200/JCO.1997.15.7.2483
Early Breast Cancer Trialists' Collaborative Group, None, Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials The Lancet. ,vol. 365, pp. 1687- 1717 ,(2005) , 10.1016/S0140-6736(05)66544-0
R. Kudachadkar, R. M. O'Regan, Aromatase inhibitors as adjuvant therapy for postmenopausal patients with early stage breast cancer. CA: A Cancer Journal for Clinicians. ,vol. 55, pp. 145- 163 ,(2005) , 10.3322/CANJCLIN.55.3.145
J.S. Tobias, Recent advances in endocrine therapy for postmenopausal women with early breast cancer: implications for treatment and prevention Annals of Oncology. ,vol. 15, pp. 1738- 1747 ,(2004) , 10.1093/ANNONC/MDH485
Elizabeth Maunsell, Mélanie Drolet, Jacques Brisson, Jean Robert, Luc Deschênes, Dietary change after breast cancer: extent, predictors, and relation with psychological distress. Journal of Clinical Oncology. ,vol. 20, pp. 1017- 1025 ,(2002) , 10.1200/JCO.20.4.1017